Fig. 3From: The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumoursBoxplots comparing the expression of CCND1, CDK4/6, MKI67, ESR1 and PGR within PAM50 subtypes. CCND1 cyclin D1 gene, CDK4/6 cyclin-dependent kinase 4/6 genes, MKI67 marker of proliferation KI-67 protein coding gene, ESR1 oestrogen receptor 1 gene, PGR progesterone receptor gene, Amp/Non-Amp CCND1 amplified/non-amplified tumours, P values (based on two-sided Student’s t test) = NS > 0.05, * < 0.05, ** < 0.01, *** < 0.001Back to article page